Accepting Applications Now
The objective of this award is to stimulate interest in digestive disease research among applicants from groups underrepresented in biomedical research through mentored research experience with a goal of encouraging promising students to pursue careers in science, medicine, and specifically basic and/or clinical digestive disease research to expand the pipeline of investigators from diverse backgrounds.
Research: I lead a research program in the field of gastrointestinal (GI) epithelial cell and developmental biology. My lab uses cutting-edge organoid and animal models to delineate fundamental mechanisms involved in GI development, homeostasis, and disease. Our current projects focus on GATA transcription factors and their roles in normal GI development, metaplasia, and cancer.
Project(s): An undergraduate student will participate in our studies of GATA4 function using human GI organoid models derived from normal, metaplastic, and malignant GI tissues. In addition to gaining experience in cutting edge organoid culture systems, the undergraduate will gain proficiency in molecular biology techniques including transcriptional profiling and chromatin immunoprecipitation.
Research: As a physician-scientist I am interested in discovering the cells and molecules involved in normal gut motor and sensory function, and how they are disrupted in disease, such as irritable bowel syndrome. Current efforts in the lab are focused on a sensory pathway we call “gut touch,” because this sensory circuit is very similar to the skin touch circuit. We use a range of cutting-edge techniques in enteric neuroscience that range from examinations of single molecules to studies in animals and humans.
Our group is a part of the Mayo Clinic’s Enteric Neuroscience Program (ENSP), which has a long and distinguished history in the field, and is composed of several labs, so there are always many interesting collaborations and discussions.
Project(s): We have several projects ongoing that we will tailor to the students’ needs and interests. These include microscopy approaches, (immunofluorescence, super-resolution microscopy), in vitro studies looking at cell and tissue function by electrophysiology and calcium imaging, and in vivo studies that ask what the gut touch system’s role is in gut physiology.
Research: My research is focused on two areas—(1) behavioral health treatments for gastrointestinal (GI) conditions, particularly disorder of gut-brain interaction (formerly called functional GI disorders); and (2) the intersection of problematic eating behaviors and GI disorders (e.g., avoidant/restrictive food intake disorder). I also collaborate on projects that investigate psychological factors in GI conditions, such as the role of GI-specific anxiety.
Project(s): We have NIH-funded research projects that investigate biological and behavioral markers of problematic eating behaviors in patients with disorders of gut-brain interaction, and randomized controlled trials of behavioral interventions for GI disorders (U01 DK112193; K23 DK131334). In the MGH Center for Neurointestinal Health, we also have a robust multidisciplinary GI Behavioral Health Program which engages multidisciplinary providers including nurse practitioners to deliver behavioral health treatments like cognitive-behavioral treatments. Our undergraduate student trainees have been involved in all aspects of the research process, including study development, recruitment, assessment, data management, data analysis, and publication. Trainees with our team select an independent project that will facilitate their research skill growth.
Research: My research is focused on the prevention of colorectal cancer using chemopreventive drugs and lifestyle interventions. I also lead research programs in the epidemiology of the gut microbiome, gastrointestinal bleeding, inflammatory bowel disease, gallstone disease, and COVID-19. I also have a laboratory that conducts translational research projects using a variety of human models, including intestinal organoids.
Project(s): If we are able to host students in person, the student can work in our laboratory conducting translational studies on human samples focused on chen-prevention of colorectal cancer with aspirin and other drug targets, as well as microbiome research. If entirely remote, the student will conduct analyses of epidemiological data related to colorectal cancer risk or COVID-19.
Research: The role of serotonin transporter (SERT) as a therapeutic target for inflammatory bowel diseases and gut-brain disorders such as post traumatic stress disorder (PTSD).
Project(s): We have a novel transgenic inducible knock-in model of SERT that can lead to overexpression of SERT in neurons or epithelial cells. The project will aim to characterize this mouse model.
Research: My research, funded by NIDDK, studies the role of the microfilament in regulating epithelial homeostasis. We have identified intestinal epithelial cell actin binding proteins as cellular stress sensors and demonstrated that dysregulation of the cellular stress signaling contributes to the pathogenesis of Crohn’s disease. Other studies in the laboratory study the function of the actin bundling protein fascin in the pathogenesis to metastatic colorectal carcinomas. Fascin is not expressed in the normal adult epithleium but its expression is upregulated in most carcinomas, including aggressive metastatic colorectal carcinomas. Fascin expression in carcinomas is always linked to increased mortality and metastatic disease. The laboratory is identifying the molecular basis for fascin’s function in metastatic colorectal carcinomas.
Project(s): Students could work with colorectal cancer cell lines to monitor changes in fascin-expressing or fascin-null cells using confocal microscopy. The student could learn to use mouse models of colorectal carcinomas. Alternatively, the student could learn how to culture, maintain and study ex vivo cultures of mouse and human enteroids/colonoids.
Research: My research group focuses on gut sensation and motility disorders which are common medical problems that include gastroesophageal reflux disease, stomach pain, chronic nausea and vomiting, gastroparesis, irritable bowel syndrome, constipation, cyclic vomiting syndrome and eating disorders. We strive to understand what the connections are between the brain and the gut that cause symptoms and how to cope with them. We also study gut physiology to understand what affects how the gut moves things from one place to the other, whether it be too slow or too fast. We have projects trying to understand the impact of these diseases in underserved communities. As a result, we work on the gut microbiome and metabolites, human physiology experiments with devices and MRI, database analysis/epidemiology/healthcare services research studies, and clinical trials.
Project(s): We have several faculty members as well as research coordinators and many trainees who would work as a team with the student. The research work for this program would be clinical/translational with patient data including data acquisition and clean up as well as analysis under our guidance. The goal would be to actively engage in the clinical research project with a topic and would hopefully lead to presentation of results and involvement in publications. We also have a specialized clinic taking care of patients which will provide opportunities to shadow and appreciate the challenges with these medical issues.
Research: My research focus is on functional bowel disorders such as irritable bowel syndrome (IBS), chronic constipation, and GERD. The IBS & Motility Center at Beth Israel Deaconess Medical Center is focused on advancing knowledge on the pathophysiology and treatment of functional gastrointestinal (FGID) and motility disorders. In addition to conducting research studies looking at the biological causes and psychosocial components of FGIDs and motility disorders, we are committed to investigating new potential treatments. Our clinical research team focuses on GI motility and functional bowel disorders. Our clinical research includes trials with a focus on alternative treatments (e.g., probiotics, placebo, vibrating capsule, etc.) and database analyses (e.g., evaluating predictors of improvement in symptoms).
Project(s): Our undergraduate students have conducted research using large nationally available datasets as well as internal patient databases. Students working with our team will utilize existing clinical databases either from our clinic or research trials to explore important clinical questions such as predicting healthcare utilization or improvement in symptoms.
Website: https://connects.catalyst.harvard.edu/Profiles/profile/1256363 and https://www.bidmc.org/centers-and-departments/digestive-disease-center/services-and-programs/ibs-and-functional-bowel-disorders-program
Research: The Margolis Lab studies the effects of neurotransmitters and inflammation on enteric nervous system development and function. The goal of Dr. Margolis’s research is to understand the enteric nervous system (ENS) and disorders that have in common an effect both on the brain and the gut, sometimes referred to as the “brain-gut axis.” She has published novel observations on the roles that enteric neurotransmitters (specifically serotonin and oxytocin) play in ENS development and how signaling from such neurotransmitters may, when abnormal, result in gastrointestinal (GI) disorders such as inflammatory bowel disease (e.g., Crohn’s disease and ulcerative colitis), motility dysfunction (e.g., chronic constipation or irritable bowel syndrome), and necrotizing enterocolitis (a devastating intestinal inflammatory disorder primarily of preterm infants). This research has recently provided important insights into how abnormalities of the ENS can arise in children with brain-gut axis disorders such as autism, antenatal antidepressant exposure, and irritable bowel syndrome.
Project(s): Students will work with mouse models of IBS, autism and antidepressant exposure.
Research: A remarkable feature of the GI tract is that it has its own intrinsic nervous system that can function rather independently to regulate a wide variety of digestive functions. The goal of our laboratory is to understand how neurons and glial cells in this enteric nervous system (ENS) interact with other cells in the gut to regulate motility and inflammation. We use mouse genetic models, in vivo and in vitro assays to tackle these questions. Our work is motivated by the conviction that a better understanding of enteric neurobiology will advance the diagnosis and treatment of digestive disease.
Project(s): The student will work on an independent project under the close mentorship of a postdoctoral fellow or senior Ph.D. student with the goals of learning how to design, perform and interpret experiments, give effective presentations, and contribute to a publication. Projects may involve cell culture, dissections, microscopy, and/or behavioral tests on mice depending on student’s interests and abilities.
Research: Neurogastroenterology and motility– understanding the mechanisms of disease and novel diagnostics and treatments for irritable bowel syndrome (IBS), gas/bloating, constipation, fecal incontinence, and gastroparesis. Current projects in the lab include 1. TNT for fecal incontinence; 2. Gut and brain interactions; 3. Food intolerance; 4. SCBDS capsule for SIBO; 5. Magnetic treatments for gastroparesis.
Project(s): Students could work on projects (1) examining bidirectional gut-brain interactions in IBS and constipation, (2) dietary fructan intolerance, diagnosis and new enzyme therapy, or (3) body posture and defecation dynamic.
Research: Research in the lab aims to understand how intestinal epithelial cells sense and interact with their surroundings and how membrane channels and transporters contribute to immune function, host-microbial symbiosis, and cellular metabolism. Projects in the lab use a variety of approaches and span several aspects of physiology and disease, including both basic science and translational research. Our lab uses high resolution quantitative imaging, electrophysiology, organoids, and mouse genetic models to investigate the cellular environment. An important aspect of our research also involves the development of novel optical tools for studying tissue and cell biology.
Project(s): Using patient-derived organoid models to understand the biology and to develop therapies for infants and children with rare and severe genetic intestinal epithelial disorders that cause diarrhea (congenital diarrheas); Investigating the role of cow’s milk peptides in intestinal innate immune function; Investigating the role of redox signaling in virus sensing in the epithelium.
Research: Inflammatory bowel disease (IBD), specifically crohn’s disease and ulcerative colitis. Recent studies defined factors associated with the development of Crohn’s disease after ileal pouch anal anastomosis, determined the value of histology in identifying Lynch syndrome in early-onset colorectal cancer patients, and compared the phenotype and genotype in adenomatous polyposis patients with and without a family history.
Project(s): Investigating the mechanisms of IBD in pregnancy.
Research: I am involved in clinical and translational research in Inflammatory Bowel Disease (IBD). Specifically, my main interests are in clinical outcomes and risk stratification among recently diagnosed IBD patients in order to understand the best way to care for patients early in their disease. In addition, I have an interest in the impact of COVID-19 on IBD patients, particularly the impact of IBD medications on COVID-19 outcomes.
Project(s): Utilize existing databases or create new database through chart review to investigate risk factors for poor outcomes among recently diagnosed patients or IBD patients with COVID-19. Organize, analyze and write up research results for abstract and/or publication in peer-reviewed journal. Activities would likely involve study design, data extraction, data cleaning, database organization/creation, and basic data analysis. Potential for cross-sectional study as well in our IBD center (administering surveys to IBD patients for example).
Recipients are selected based on their interest in biomedical and digestive disease research, engagement with the research proposal and proposed mentor, demonstrated need for the program, and likelihood of benefiting from the experience.
The application deadline is January 12, 2022. Applications are only accepted through the AGA Grants Management System. Click the “Apply Now” button to create an account and submit an application. You may preview the application as it will appear on the AGA Grant Management System before beginning an application. Please note that this preview is for reference only and all applications are completed online.
AGA gratefully acknowledges the Aman Armaan Ahmed Family for supporting this program.
Be part of AGA Giving Day and help the AGA Research Foundation foster and support the careers of underrepresented researchers. Donate now through Oct. 26.
AGA grants supported by Giving Day will help spark diverse students’ interest in GI research careers and launch underrepresented investigators’ academic research careers.